Volume 69, Issue 6 , Pages 248-253, June 2006
Association of Insulin Resistance and Hematologic Parameters: Study of a Middle-aged and Elderly Chinese Population in Taiwan
Article Outline
Background
Chronic inflammation is a common feature related to changes in hematologic parameters in insulin resistance. The aims of this study were to explore the relationship between hematologic parameters and insulin resistance, and to establish a gerontologic profile for following studies.
Methods
Residents aged over 40 years in 3 major townships in I-Lan County participating in the Adult Health Examination were invited for the study. Diagnosis of diabetes mellitus (DM) was done according to American Diabetes Association criteria. Insulin resistance was measured by homeostasis model assessment (HOMA-IR), and subjects with the highest tertile of HOMA-IR were defined as being insulin resistant. Hematologic parameters including white blood cell (WBC) count, red blood cell (RBC) count, hemoglobin, and platelet count were measured for comparisons.
Results
A total of 857 subjects (mean age, 64.6 ± 11.2 years; male/female, 373/484) participated in this study. Their mean body mass index (BMI) was 24.5 ± 3.7 kg/m2, and 42.4% of them were obese and 21.8% were overweight. The overall prevalence of DM was 15.4% (7.7% were previously diagnosed and 7.7% were newly diagnosed), and impaired fasting glucose was 7.2%. Trend analyses confirmed that age, BMI, HOMA-IR, WBC and platelet counts were significantly increased as glycemic metabolism exacerbated (p = 0.007, < 0.001, < 0.001, < 0.001 and 0.025, respectively). Compared with insulin-sensitive subjects, insulin-resistant subjects were more likely to be females (70.2% vs. 49.7%, p < 0.001), and had significantly higher BMI (26.2 ± 3.9 kg/m2 vs. 23.7 ± 3.3 kg/m2, p < 0.001), HOMA-IR (3.6 ± 3.5 vs. 0.7 ± 0.3, p 0.001), WBC count (6686.9 ± 1889.2/mm3 vs. 5942.9 ± 1740.4/mm3, p < 0.001), and platelet count (243.5 ± 70.9 × 103/mm3 vs. 231.0 ± 62.2 × 103/mm3, p = 0.011), but not age (64.5 ± 11.0 years vs. 64.6 ± 11.4 years, p = 0.93) or RBC count (4.6 ± 0.6 M/mm3 vs. 4.6 ± 0.6 M/mm3, p = 0.76). When age and sex were controlled, HOMA-IR significantly correlated with WBC count (γ = 0.23, p < 0.001) and platelet count (γ = 0.09, p = 0.007). However, by multiple logistic regression, female gender, overweight and obesity, and elevated WBC count were all found to be independent risk factors of insulin resistance, but age, RBC and platelet counts were not.
Conclusion
Elevated WBC count but not RBC count was significantly associated with insulin resistance and glycemic metabolism. The relationship between platelet count and insulin resistance deserves further investigations.
Key Words: blood platelet count , diabetes mellitus , hemoglobin , insulin resistance , white blood cell count
No full text is available. To read the body of this article, please view the PDF online.
References
- . Banting lecture 1988. Role of insulin resistance in human diseases . Diabetes . 1988;37:1595–1607
- . Insulin resistance syndrome: options for treatment . South Med J . 1999;92:2–15
- . The deadly quartet- the insulin resistance syndrome . South Med J . 1997;90:1162–1168
- . Early growth response factor-I mediates insulin-inducible vascular endothelial cell proliferation and regrowth after injury . J Cell Biochem . 2001;81:523–534
- . Hyperinsulinemia as an independent risk factor for ischemic heart disease . N Engl J Med . 1996;334:952–957
- . The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity . J Am Soc Nephrol . 2004;15:2792–2800
- . NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X . Diabetologia . 1997;40:1286–1292
- . White blood cell count and the risk of impaired fasting glucose or type II diabetes in middle-aged Japanese men . Diabetologia . 2002;45:42–48
- . New aspects of insulin resistance syndrome: impact on haematological parameters . Diabetologia . 2001;44:1232–1237
- . Hypertriglyceridemia, insulin resistance, and the metabolic syndrome . Am J Cardiol . 1999;83:25–29
- . Prospective analysis of the insulin resistance syndrome (syndrome X) . Diabetes . 1992;41:715–722
- . The leukocyte count: correlates and relationship to coronary risks factors: the CARDIA study . Int J Epidemiol . 1990;19:889–893
- . Leukocyte count in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study . Am J Epidemiol . 1992;136:527–537
- . Relationship between hemoglobin and cardiovascular risk factors in young adults . J Clin Epidemiol . 1993;46:1257–1266
- . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man . Diabetologia . 1985;28:412–419
- Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes . Diabetes Care . 2001;24:362–365
- . Diagnosing insulin resistance in the general population . Diabetes Care . 2001;24:460–464
- . Metabolic characteristics and insulin resistance of impaired fasting glucose among the middle-aged and elderly Taiwanese . Diabetes Res Clin Pract . 2006;71:170–176
- . The Asia-Pacific Perspective: Redefining Obesity and Its Treatment . Geneva: WHO; 2000;
- . Report of the expert committee on the diagnosis and classification of diabetes mellitus . Diabetes Care . 1997;20:1183–1197
- . Protein-protein interaction in insulin signaling and the molecular mechanism of insulin resistance . J Clin Invest . 1999;103:931–943
- Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo . J Clin Endocrinol Metab . 1997;82:41196–41200
- . Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes . Mol Cell Biol . 1992;12:1789–1797
- . Leukocytes and the risk of ischemic diseases . JAMA . 1987;257:2318–2324
- . Stimulatory effect of human insulin on erythroid progenitors (CFU-E and BFU-E) in human CD34+ separated bone marrow cells and the relationship between insulin and erythropoietin . Stem Cell . 1994;12:329–338
- . Insulin stimulates cord blood erythroid progenitor growth: evidence for an aetiological role in neonatal polycythaemia . Br J Haematol . 1986;64:503–511
- . Association with hematological parameters and metabolic syndrome components in a Chinese population . J Diabetes Complication . 2004;18:322–327
- . Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release . J Clin Invest . 1994;94:1172–1179
- Impaired insulin induced platelet antiaggregating effect in obesity and in obese NIDDM patients . Diabetes . 1995;44:1318–1322
- . Insulin directly reduces platelet sensitivity to aggregating agents: studies in vitro and in vivo . Diabetes . 1988;37:780–786
- . Platelet dysfunction in type 2 diabetes . Diabetes Care . 2001;24:1476–1485
- Platelet count is independently associated with insulin resistance in nonobese Japanese type 2 diabetic patients . Metabolism . 2003;52:1246–1249
PII: S1726-4901(09)70251-5
doi:10.1016/S1726-4901(09)70251-5
© 2006 Elsevier. Published by Elsevier Inc. All rights reserved.
Volume 69, Issue 6 , Pages 248-253, June 2006
